Login
$OSCR
$31.33 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Mark T. Bertolini
Chief Executive Officer and Director
69 Not stated $1,149,308
Richard Scott Blackley
Chief Financial Officer
57 Since 2023
3 years
Not reported
Joshua Kushner
Co-Founder, Vice Chair of the Board and Director
40 Not stated Not reported
Adam McAnaney
Chief Legal Officer
49 Since 2025
1 year
$7,129,097
Victoria Baltrus
Chief Accounting Officer
Title from the Form 4 dated Sep 3, 2026
Not stated Not stated Not reported
Janet Liang
President of Oscar Insurance
58 Since 2025
1 year
$10,400,673

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
6 of 6
stated in the proxy
Director Independent 2025 pay Source
Vanessa Ames Wittman
Independent $312,496
Laura Lang
Independent $312,496
Jeffery Boyd
Independent $409,996
William (Bill) J. Gassen III
Independent $277,991
David Alexander Plouffe
Independent $284,996
Sankaran
Independent Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

8 disclosed in the proxy filed Apr 22, 2026
Sanford Health
Mr. Gassen is the Chief Executive Officer of Sanford Health.
Amount not stated
fiscal year 2025 through April 10, 2026

Services agreement under which the Company provides campaign builder and related services; the Company also makes payments to Sanford Health affiliates for member claims.

With Sanford Health Plan Open in proxy
Thrive Capital
Beneficial holder of 5% of our capital stock at the time of the Investment Agreement; Mr. Kushner is its Founder and Chief Executive Officer.
$35.0 million
2022

Purchase of $35.0 million aggregate principal amount of 2031 Convertible Senior Notes under the Investment Agreement.

With the Company Open in proxy
Dragoneer
Beneficial holder of 5% of our capital stock at the time of the Investment Agreement.
$250 million
2022

Purchase of $250 million aggregate principal amount of 2031 Convertible Senior Notes under the Investment Agreement.

With the Company Open in proxy
Dragoneer
Beneficial holder of 5% of our capital stock at the time of the Investment Agreement.
$8.0 million
2025

Cash fee paid under a Letter Agreement in connection with the Amendment permitting the 2030 Notes offering.

With the Company Open in proxy
Thrive Capital
Beneficial holder of 5% of our capital stock at the time of the Investment Agreement; Mr. Kushner is its Founder and Chief Executive Officer.
Approximately $1.1 million
2025

Cash fee paid under a Letter Agreement in connection with the Amendment permitting the 2030 Notes offering.

With the Company Open in proxy
Dragoneer
Beneficial holder of 5% of our capital stock at the time of the Investment Agreement.
Up to $250.0 million aggregate principal amount
2025

Exchange Agreement under which Dragoneer could exchange its 2031 Notes for Class A common stock and cash, and received an inducement payment; Dragoneer exchanged its notes in November 2025.

With the Company Open in proxy
Thrive Capital
Mr. Schlosser and entities affiliated with Mr. Schlosser and Thrive Capital are holders of capital stock party to the IRA.
Amount not stated

Thirteenth Amended and Restated Investors' Rights Agreement granting registration rights and imposing affirmative obligations on the Company.

Mr. Bertolini
Our CEO.
$11.92 million
April 3, 2026

Sale of 1,000,000 shares of Class A common stock to the CEO in a private placement at $11.92 per share.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support